<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34979977</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2377</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>03</Day></PubDate></JournalIssue><Title>BMC neurology</Title><ISOAbbreviation>BMC Neurol</ISOAbbreviation></Journal><ArticleTitle>Assessment of bidirectional relationships between 98 genera of the human gut microbiota and amyotrophic lateral sclerosis: a 2-sample Mendelian randomization study.</ArticleTitle><Pagination><StartPage>8</StartPage><MedlinePgn>8</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12883-021-02522-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Growing evidence suggests a mutual interaction between gut microbiome alterations and ALS pathogenesis. However, previous studies were susceptible to potential confounding factors and reverse causation bias, likely leading to inconsistent and biased results.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To decipher the potentially mutual relationship between gut microbiota and ALS, we used a bidirectional two-sample MR approach to examine the associations between the gut microbiome and ALS.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Using the inverse variance-weighted method, OTU10032 unclassified Enterobacteriaceae species-level OTU and unclassified Acidaminococcaceae were associated with a higher risk of ALS (per relative abundance: OR, 1.04; 95% CI, 1.01-1.07; P&#x2009;=&#x2009;0.011 and OR, 1.02; 95% CI, 1.01-1.04; P&#x2009;=&#x2009;0.009, respectively). Importantly, Gamma-Glu-Phe was showed potential deleterious effects on the risk of ALS (genetically predicted per a 1-standard deviation increase in the level of Gamma-Glu-Phe: OR, 1.96; 95% CI, 1.50-2.55; P&#x2009;=&#x2009;0.012). Sensitivity analysis of the two candidate genera and metabolites using the MR-Egger and weighted-median methods produced similar estimates, and no horizontal pleiotropy or outliers were observed. Intriguingly, genetically predicted ALS was associated with an increase in the relative abundance of OTU4607_Sutterella (per 1-unit higher log odds: &#x3b2;, 2.23; 95% CI, 1.27-3.18; P&#x2009;=&#x2009;0.020) and Lactobacillales_ORDER (per 1-unit higher log odds: &#x3b2;, 0.51; 95% CI, 0.09-0.94; P&#x2009;=&#x2009;0.019).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings provide novel evidence supporting the bidirectional relationship between the gut microbiota and ALS. These results may contribute to designing microbiome- and microbiome-dependent metabolite interventions in future ALS clinical trials.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Linjing</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing, 100191, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Municipal Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhuang</LastName><ForeName>Zhenhuang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Epidemiology &amp; Biostatistics, School of Public Health, Peking University, Beijing, 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Gan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing, 100191, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Municipal Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Huang</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Epidemiology &amp; Biostatistics, School of Public Health, Peking University, Beijing, 100191, China. huangtao@bjmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Molecular Cardiovascular Sciences (Peking University), Ministry of Education, Beijing, China. huangtao@bjmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Fan</LastName><ForeName>Dongsheng</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing, 100191, China. dsfan2010@aliyun.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Municipal Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, China. dsfan2010@aliyun.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Neurol</MedlineTA><NlmUniqueID>100968555</NlmUniqueID><ISSNLinking>1471-2377</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015984" MajorTopicYN="N">Causality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057182" MajorTopicYN="N">Mendelian Randomization Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Bidirectional relationships</Keyword><Keyword MajorTopicYN="N">Gamma-glutamyl amino acids</Keyword><Keyword MajorTopicYN="N">Gut microbiota</Keyword><Keyword MajorTopicYN="N">Two-sample Mendelian randomization</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>4</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34979977</ArticleId><ArticleId IdType="pmc">PMC8721912</ArticleId><ArticleId IdType="doi">10.1186/s12883-021-02522-z</ArticleId><ArticleId IdType="pii">10.1186/s12883-021-02522-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, de Carvalho M, Ince PG, Lin C, Miller RG, Mitsumoto H, et al. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 2013;12:310&#x2013;322. doi: 10.1016/S1474-4422(13)70036-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70036-X</ArticleId><ArticleId IdType="pmc">PMC4565161</ArticleId><ArticleId IdType="pubmed">23415570</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T, Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 2011;10:253&#x2013;263. doi: 10.1016/S1474-4422(11)70015-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70015-1</ArticleId><ArticleId IdType="pubmed">21349440</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011;10:75&#x2013;82. doi: 10.1016/S1474-4422(10)70224-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70224-6</ArticleId><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Bander Z, Nitert MD, Mousa A, Naderpoor N. The gut microbiota and inflammation: an overview. Int J Environ Res Public Health. 2020;17.</Citation></Reference><Reference><Citation>Vinolo MA, Rodrigues HG, Nachbar RT, Curi R. Regulation of inflammation by short chain fatty acids. Nutrients. 2011;3:858&#x2013;876. doi: 10.3390/nu3100858.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu3100858</ArticleId><ArticleId IdType="pmc">PMC3257741</ArticleId><ArticleId IdType="pubmed">22254083</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheithauer TPM, Rampanelli E, Nieuwdorp M, Vallance BA, Verchere CB, van Raalte DH, Herrema H. Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Front Immunol. 2020;11:571731. doi: 10.3389/fimmu.2020.571731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.571731</ArticleId><ArticleId IdType="pmc">PMC7596417</ArticleId><ArticleId IdType="pubmed">33178196</ArticleId></ArticleIdList></Reference><Reference><Citation>Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, Blanchard C, Junt T, Nicod LP, Harris NL, Marsland BJ. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med. 2014;20:159&#x2013;166. doi: 10.1038/nm.3444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3444</ArticleId><ArticleId IdType="pubmed">24390308</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnenburg JL, B&#xe4;ckhed F. Diet-microbiota interactions as moderators of human metabolism. Nature. 2016;535:56&#x2013;64. doi: 10.1038/nature18846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature18846</ArticleId><ArticleId IdType="pmc">PMC5991619</ArticleId><ArticleId IdType="pubmed">27383980</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, Yi J, Zhang YG, Zhou J, Sun J. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model. Physiol Rep. 2015;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4425962</ArticleId><ArticleId IdType="pubmed">25847918</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YG, Wu S, Yi J, Xia Y, Jin D, Zhou J, Sun J. Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis. Clin Ther. 2017;39:322&#x2013;336. doi: 10.1016/j.clinthera.2016.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2016.12.014</ArticleId><ArticleId IdType="pmc">PMC5344195</ArticleId><ArticleId IdType="pubmed">28129947</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X, Wang X, Yang S, Meng F, Wang X, Wei H, Chen T. Evaluation of the microbial diversity in amyotrophic lateral sclerosis using high-throughput sequencing. Front Microbiol. 2016;7:1479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5028383</ArticleId><ArticleId IdType="pubmed">27703453</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzini L, Mogna L, De Marchi F, Amoruso A, Pane M, Aloisio I, Cionci NB, Gaggia F, Lucenti A, Bersano E, et al. Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies. J Clin Gastroenterol. 2018;52(Suppl 1):S68&#x2013;s70. doi: 10.1097/MCG.0000000000001042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCG.0000000000001042</ArticleId><ArticleId IdType="pubmed">29782468</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D, Hiergeist A, Adis C, Mayer B, Gessner A, Ludolph AC, Weishaupt JH. The fecal microbiome of ALS patients. Neurobiol Aging. 2018;61:132&#x2013;137. doi: 10.1016/j.neurobiolaging.2017.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.09.023</ArticleId><ArticleId IdType="pubmed">29065369</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacher E, Bashiardes S, Shapiro H, Rothschild D, Mor U, Dori-Bachash M, Kleimeyer C, Moresi C, Harnik Y, Zur M, et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 2019;572:474&#x2013;480. doi: 10.1038/s41586-019-1443-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1443-5</ArticleId><ArticleId IdType="pubmed">31330533</ArticleId></ArticleIdList></Reference><Reference><Citation>Sattar N, Preiss D. Reverse causality in cardiovascular epidemiological research: more common than imagined? Circulation. 2017;135:2369&#x2013;2372. doi: 10.1161/CIRCULATIONAHA.117.028307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.028307</ArticleId><ArticleId IdType="pubmed">28606949</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips AN, Smith GD. How independent are "independent" effects? Relative risk estimation when correlated exposures are measured imprecisely. J Clin Epidemiol. 1991;44:1223&#x2013;1231. doi: 10.1016/0895-4356(91)90155-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0895-4356(91)90155-3</ArticleId><ArticleId IdType="pubmed">1941017</ArticleId></ArticleIdList></Reference><Reference><Citation>Fewell Z, Davey Smith G, Sterne JA. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study. Am J Epidemiol. 2007;166:646&#x2013;655. doi: 10.1093/aje/kwm165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwm165</ArticleId><ArticleId IdType="pubmed">17615092</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27:1133&#x2013;1163. doi: 10.1002/sim.3034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.3034</ArticleId><ArticleId IdType="pubmed">17886233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding M, Huang T, Bergholdt HK, Nordestgaard BG, Ellervik C, Qi L. Dairy consumption, systolic blood pressure, and risk of hypertension: Mendelian randomization study. Bmj. 2017;356:j1000. doi: 10.1136/bmj.j1000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j1000</ArticleId><ArticleId IdType="pmc">PMC6168037</ArticleId><ArticleId IdType="pubmed">28302601</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng T, Smith CE, Li C, Huang T. Childhood BMI and adult type 2 diabetes, coronary artery diseases, chronic kidney disease, and Cardiometabolic traits: a Mendelian randomization analysis. Diabetes Care. 2018;41:1089&#x2013;1096. doi: 10.2337/dc17-2141.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc17-2141</ArticleId><ArticleId IdType="pubmed">29483184</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Tang L, Huang T, Fan D. Life course adiposity and amyotrophic lateral sclerosis: a Mendelian randomization study. Ann Neurol. 2020;87:434&#x2013;441. doi: 10.1002/ana.25671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25671</ArticleId><ArticleId IdType="pubmed">31916305</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression. Int J Epidemiol. 2015;44:512&#x2013;525. doi: 10.1093/ije/dyv080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyv080</ArticleId><ArticleId IdType="pmc">PMC4469799</ArticleId><ArticleId IdType="pubmed">26050253</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol. 2011;40:740&#x2013;752. doi: 10.1093/ije/dyq151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyq151</ArticleId><ArticleId IdType="pmc">PMC3147064</ArticleId><ArticleId IdType="pubmed">20813862</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Thingholm LB, Skiecevi&#x10d;ien&#x117; J, Rausch P, Kummen M, Hov JR, Degenhardt F, Heinsen FA, R&#xfc;hlemann MC, Szymczak S, et al. Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota. Nat Genet. 2016;48:1396&#x2013;1406. doi: 10.1038/ng.3695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3695</ArticleId><ArticleId IdType="pmc">PMC5626933</ArticleId><ArticleId IdType="pubmed">27723756</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkasir R, Li J, Li X, Jin M, Zhu B. Human gut microbiota: the links with dementia development. Protein Cell. 2017;8:90&#x2013;102. doi: 10.1007/s13238-016-0338-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-016-0338-6</ArticleId><ArticleId IdType="pmc">PMC5291774</ArticleId><ArticleId IdType="pubmed">27866330</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan NA, Thompson JR. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-egger regression: the role of the I2 statistic. Int J Epidemiol. 2016;45:1961&#x2013;1974. doi: 10.1093/ije/dyw252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyw252</ArticleId><ArticleId IdType="pmc">PMC5446088</ArticleId><ArticleId IdType="pubmed">27616674</ArticleId></ArticleIdList></Reference><Reference><Citation>Geevasinga N, Menon P, &#xd6;zdinler PH, Kiernan MC, Vucic S. Pathophysiological and diagnostic implications of cortical dysfunction in ALS. Nat Rev Neurol. 2016;12:651&#x2013;661. doi: 10.1038/nrneurol.2016.140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.140</ArticleId><ArticleId IdType="pubmed">27658852</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Lv X, Du H, Wu D, Wang M. Causal effects of serum metabolites on amyotrophic lateral sclerosis: a Mendelian randomization study. Prog Neuro-Psychopharmacol Biol Psychiatry. 2020;97:109771. doi: 10.1016/j.pnpbp.2019.109771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2019.109771</ArticleId><ArticleId IdType="pubmed">31669200</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin SY, Fauman EB, Petersen AK, Krumsiek J, Santos R, Huang J, Arnold M, Erte I, Forgetta V, Yang TP, et al. An atlas of genetic influences on human blood metabolites. Nat Genet. 2014;46:543&#x2013;550. doi: 10.1038/ng.2982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2982</ArticleId><ArticleId IdType="pmc">PMC4064254</ArticleId><ArticleId IdType="pubmed">24816252</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, et al. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron. 2018;97:1268&#x2013;1283. doi: 10.1016/j.neuron.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemani G, Bowden J, Davey Smith G. Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum Mol Genet. 2018;27:R195&#x2013;r208. doi: 10.1093/hmg/ddy163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy163</ArticleId><ArticleId IdType="pmc">PMC6061876</ArticleId><ArticleId IdType="pubmed">29771313</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-egger method. Eur J Epidemiol. 2017;32:377&#x2013;389. doi: 10.1007/s10654-017-0255-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-017-0255-x</ArticleId><ArticleId IdType="pmc">PMC5506233</ArticleId><ArticleId IdType="pubmed">28527048</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, et al. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson&#x2019;s Disease. Cell. 2016;167:1469&#x2013;1480. doi: 10.1016/j.cell.2016.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.11.018</ArticleId><ArticleId IdType="pmc">PMC5718049</ArticleId><ArticleId IdType="pubmed">27912057</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharon G, Cruz NJ, Kang DW, Gandal MJ, Wang B, Kim YM, Zink EM, Casey CP, Taylor BC, Lane CJ, et al. Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice. Cell. 2019;177:1600&#x2013;1618. doi: 10.1016/j.cell.2019.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.05.004</ArticleId><ArticleId IdType="pmc">PMC6993574</ArticleId><ArticleId IdType="pubmed">31150625</ArticleId></ArticleIdList></Reference><Reference><Citation>Tardito S, Oudin A, Ahmed SU, Fack F, Keunen O, Zheng L, Miletic H, Sakariassen P, Weinstock A, Wagner A, et al. Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma. Nat Cell Biol. 2015;17:1556&#x2013;1568. doi: 10.1038/ncb3272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb3272</ArticleId><ArticleId IdType="pmc">PMC4663685</ArticleId><ArticleId IdType="pubmed">26595383</ArticleId></ArticleIdList></Reference><Reference><Citation>Gough EK, Stephens DA, Moodie EE, Prendergast AJ, Stoltzfus RJ, Humphrey JH, Manges AR. Linear growth faltering in infants is associated with Acidaminococcus sp and community-level changes in the gut microbiota. Microbiome. 2015;3:24. doi: 10.1186/s40168-015-0089-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-015-0089-2</ArticleId><ArticleId IdType="pmc">PMC4477476</ArticleId><ArticleId IdType="pubmed">26106478</ArticleId></ArticleIdList></Reference><Reference><Citation>Kundu P, Blacher E, Elinav E, Pettersson S. Our gut microbiome: the evolving inner self. Cell. 2017;171:1481&#x2013;1493. doi: 10.1016/j.cell.2017.11.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.11.024</ArticleId><ArticleId IdType="pubmed">29245010</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzini L, Mogna L, De Marchi F, Amoruso A, Pane M, Aloisio I, Cionci NB, Gagg&#xec;a F, Lucenti A, Bersano E, et al: Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies. J Clin Gastroenterol. 2018;52 Suppl 1:S68-s70, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition &amp; Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">29782468</ArticleId></ArticleIdList></Reference><Reference><Citation>Erber AC, Cetin H, Berry D, Schernhammer ES. The role of gut microbiota, butyrate and proton pump inhibitors in amyotrophic lateral sclerosis: a systematic review. Int J Neurosci. 2020;130:727&#x2013;735. doi: 10.1080/00207454.2019.1702549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00207454.2019.1702549</ArticleId><ArticleId IdType="pubmed">31870202</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghadge GD, Kay BK, Drigotas C, Roos RP. Single chain variable fragment antibodies directed against SOD1 ameliorate disease in mutant SOD1 transgenic mice. Neurobiol Dis. 2019;121:131&#x2013;137. doi: 10.1016/j.nbd.2018.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.08.021</ArticleId><ArticleId IdType="pubmed">30176351</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>